(Total Views: 485)
Posted On: 11/08/2019 10:47:52 AM
Post# of 154880
Right now there is no money to commercialize the drug
That's it. No matter how good the science is, Nader says that they will need tens of millions of dollars to commercialize leronlimab. I'm very hopeful a licensing deal will be struck, and the one with the expired NBA was with a company that has a sales force ready to go, but if there is little money upfront then there will be more dilution to get to the milestone payments.
And if there is no deal...I have no idea how the company will raise the money to pay Syneos to sell leronlimab and whatever else it takes to get through commercialization. That would take up to 150 million shares at .30 and there is no way the company could sell anywhere near that, not by a long shot.
The real key is not the BLA but noteworthy preliminary results in NASH and/or TNBC. That will bring the money in. I bought another 20,000 last week to bring my total to 170,000 because I feel good about those indications. But it's a big gamble and a worst-case scenario is possible if no deal and if we get mediocre NASH/cancer results.
That's it. No matter how good the science is, Nader says that they will need tens of millions of dollars to commercialize leronlimab. I'm very hopeful a licensing deal will be struck, and the one with the expired NBA was with a company that has a sales force ready to go, but if there is little money upfront then there will be more dilution to get to the milestone payments.
And if there is no deal...I have no idea how the company will raise the money to pay Syneos to sell leronlimab and whatever else it takes to get through commercialization. That would take up to 150 million shares at .30 and there is no way the company could sell anywhere near that, not by a long shot.
The real key is not the BLA but noteworthy preliminary results in NASH and/or TNBC. That will bring the money in. I bought another 20,000 last week to bring my total to 170,000 because I feel good about those indications. But it's a big gamble and a worst-case scenario is possible if no deal and if we get mediocre NASH/cancer results.
(0)
(0)
